A major clinical trial, led by experts at the University of Nottingham, will investigate whether some of the 1.3 million most vulnerable people on long-term immune suppressing medicines can mount a more robust immune response to Covid-19 booster jabs by interrupting their treatment for two weeks after vaccination. The VROOM trial, which will have implications […]